252 related articles for article (PubMed ID: 30077521)
1. The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study.
Buda A; Restaino S; Di Martino G; De Ponti E; Monterossi G; Dinoi G; Magni S; Quagliozzi L; Dell'Orto F; Ciccarone F; Lamanna M; Scambia G; Landoni F; Fanfani F
Eur J Surg Oncol; 2018 Oct; 44(10):1562-1567. PubMed ID: 30077521
[TBL] [Abstract][Full Text] [Related]
2. The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: An Italian retrospective analysis of two reference centers.
Buda A; Di Martino G; Restaino S; De Ponti E; Monterossi G; Giuliani D; Ercoli A; Dell'Orto F; Dinoi G; Grassi T; Scambia G; Fanfani F
Gynecol Oncol; 2017 Dec; 147(3):528-534. PubMed ID: 29032824
[TBL] [Abstract][Full Text] [Related]
3. Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy.
Buda A; Gasparri ML; Puppo A; Mereu L; De Ponti E; Di Martino G; Novelli A; Tateo S; Muller M; Landoni F; Papadia A
Gynecol Oncol; 2018 Aug; 150(2):261-266. PubMed ID: 29887483
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
Ducie JA; Eriksson AGZ; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Soslow RA; Keeney GL; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2017 Dec; 147(3):541-548. PubMed ID: 28965698
[TBL] [Abstract][Full Text] [Related]
5. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M;
Ann Surg Oncol; 2017 Jun; 24(6):1660-1666. PubMed ID: 28058558
[TBL] [Abstract][Full Text] [Related]
6. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
[TBL] [Abstract][Full Text] [Related]
8. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
El-Agwany AS; Meleis MH
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
[TBL] [Abstract][Full Text] [Related]
9. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis.
Holloway RW; Gupta S; Stavitzski NM; Zhu X; Takimoto EL; Gubbi A; Bigsby GE; Brudie LA; Kendrick JE; Ahmad S
Gynecol Oncol; 2016 May; 141(2):206-210. PubMed ID: 26905211
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study.
Bogani G; Papadia A; Buda A; Casarin J; Di Donato V; Gasparri ML; Plotti F; Pinelli C; Paderno MC; Lopez S; Perrone AM; Barra F; Guerrisi R; Brusadelli C; Cromi A; Ferrari D; Chiapp V; Signorelli M; Leone Roberti Maggiore U; Ditto A; Palaia I; Ferrero S; De Iaco P; Angioli R; Panici PB; Ghezzi F; Landoni F; Mueller MD; Raspagliesi F
Gynecol Oncol; 2021 Apr; 161(1):122-129. PubMed ID: 33485641
[TBL] [Abstract][Full Text] [Related]
13. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
Schlappe BA; Weaver AL; McGree ME; Ducie J; Zahl Eriksson AG; Dowdy SC; Cliby WA; Glaser GE; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2020 Jan; 156(1):62-69. PubMed ID: 31776037
[TBL] [Abstract][Full Text] [Related]
14. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
15. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Plante M
Gynecol Oncol; 2017 Dec; 147(3):549-553. PubMed ID: 28942993
[TBL] [Abstract][Full Text] [Related]
16. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Daraï E
Lancet Oncol; 2011 May; 12(5):469-76. PubMed ID: 21489874
[TBL] [Abstract][Full Text] [Related]
17. Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping.
Schiavone MB; Scelzo C; Straight C; Zhou Q; Alektiar KM; Makker V; Soslow RA; Iasonos A; Leitao MM; Abu-Rustum NR
Ann Surg Oncol; 2017 Jul; 24(7):1965-1971. PubMed ID: 28258415
[TBL] [Abstract][Full Text] [Related]
18. Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer.
Tanner E; Puechl A; Levinson K; Havrilesky LJ; Sinno A; Secord AA; Fader AN; Lee PS
Gynecol Oncol; 2017 Dec; 147(3):535-540. PubMed ID: 29056441
[TBL] [Abstract][Full Text] [Related]
19. Impact of sentinel lymph node mapping on survival in patients with high-risk endometrial cancer in the early stage: A matched cohort study.
Jaafar E; Gaultier V; Wohrer H; Estevez JP; Gonthier C; Koskas M
Int J Gynaecol Obstet; 2024 May; 165(2):677-684. PubMed ID: 38226675
[TBL] [Abstract][Full Text] [Related]
20. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.
Barlin JN; Khoury-Collado F; Kim CH; Leitao MM; Chi DS; Sonoda Y; Alektiar K; DeLair DF; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2012 Jun; 125(3):531-5. PubMed ID: 22366409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
